ABSTRACT In vivo studies of murein biosynthesis show that newly synthesized murein unexpectedly differs in its chemical composition from preexisting murein. New murein is loosely crosslinked with the preexisting sacculus; in a maturation process involving further transpeptidation, the final stage of crosslinkage in murein is achieved. Newly inserted murein initially carries pentapeptide subunits, which are the donor of the secondary transpeptidation reaction. In mutants with defective penicillin-binding protein 4 the secondary transpeptidation step is abolished. Uncoupling ofthe secondary transpeptidation reaction from crosslink formation during the initial insertion ofnew murein was also found in a mutant with a defect in lipoprotein biosynthesis. We conclude that the initial transpeptidation ofmurein and crosslink formation during the maturation of newly inserted murein are catalyzed by two different enzyme systems.
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During growth and division, the bacterial cell wall undergoes controlled modifications in size and shape. These modifications reflect alterations of the murein sacculus, which maintains cellular shape (1, 2) . Murein biosynthesis is subject to control both in space and in time (3, 4) . An understanding of bacterial morphogenesis consequently requires detailed information of the sequence of events by which new subunits are integrated into the growing sacculus.
The biosynthesis of murein precursors has been elucidated in detail by in vitro studies (5, 6) . The mode ofinsertion ofthese precursors into the preexisting polymer murein in the growing cell and its possible processing, however, are still obscure. We describe here in vivo studies which show that newly synthesized murein unexpectedly differs in its chemical composition from preexisting murein. In a maturation process the final composition of mature murein is achieved. The (1 Ci = 3.7 X 1010 becquerels). After labeling as indicated in the text, 2-ml samples ofthe cultures were boiled in 8 ml of4% sodium dodecyl sulfate with 1% 2-mercaptoethanol and kept for 30 min at 95°C. The samples were cooled to 30°C and 75 pd of a suspension of unlabeled sacculi (murein, 2.5 mg/ml) was added as a carrier. After centrifugation (100,000 X g, 30 min at 250C), the pellets were washed once in 9 ml ofwater by centrfugation under identical conditions, and then repeatedly in 150 A1 of water by centrifugation for 5 min at 100,000 X g in a Beckman Airfuge until the concentration of sodium dodecyl sulfate was below 0.001% when measured as described (9) . Finally, the pellets were resuspended in 300 ,ul of 0.05 M ammonium acetate, supplemented with hen egg-white lysozyme at 100 ,.g/ml, and incubated overnight at 37C. The lysozyme digests were lyophilized, resuspended in 10 ul of water, and fractionated by paper chromatography (10) . The dried chromatograms were cut into strips (2 x 0.5 cm), and radioactivity was determined by liquid scintillation counting. In samples containing vancomycin, in contrast with untreated controls, 3H-labeled fragments migrated together with the '4C-labeled pentapeptide tracer. After correction for background, the tritium counts were taken as a measure of the amount ofpentapeptide subunits in newly synthesized murein.
RESULTS
Initial Insertion of New Murein. Murein is a polymer in which linear glycan chains are interlinked by peptide bridges. New building blocks have to be inserted into such a network either by elongation of preexisting glycan chains via transglycosylation or by formation of new peptide bonds. The extent to which glycan chains are interlinked can be determined by assaying the relative amounts of the crosslinked muropeptides, C3 and C4, liberated from isolated sacculi by lysozyme digestion. In mutants that require the murein-specific A2pm acid for growth, the composition of newly synthesized murein could be compared with that of preexisting polymer in double-label experiments ( Fig. 1) .
Pulse labeling of new murein with [3H]A2pm of very high specific activity in exponentially growing cells revealed the formation of peptide bonds after very short labeling times (Fig.  1B) . Interestingly, however, the amount of peptide crosslinks in the new 3H-labeled murein was significantly lower than that in the '4C-labeled murein, whose composition represents the average composition of the total murein. Analysis of the time course of crosslink formation indicated that the newly synthesized murein reached the same extent of crosslinkage as found in the '4C-labeled murein in two consecutive transpeptidation reactions ( (16) . We assumed that processing of new murein via transpeptidation would require the existence ofpentapeptide subunits in the sacculus. Necessarily, the formation of additional peptide crosslinks should be paralleled by a decrease in the number of pentapeptide subunits. This has been found. Pentapeptide subunits were liberated from isolated sacculi by lysozyme digestion and identified by their ability to specifically bind to vancomycin; the pentapeptide-vancomycin complexes were identified by paper chromatography. About 2.7% ofall free peptide chains in the pulse-labeled new murein were found to be pentapeptides. This value decreases concomitantly with the formation of crosslinks during processing of new murein (Fig. 2) . However, the number of pentapeptide subunits detected was only about halfofthat expected to account for the increase in crosslinkage during the processing of murein. We assume that the lower value is the result ofdegradation of some pentapeptide units by endogenous carboxypeptidase I during the processing of the samples.
The Two Transpeptidation Steps Can Be Uncoupled from Each Other. The existence of two independent transpeptidation systems, one involved in the initial insertion ofnew murein, the other catalyzing the processing ofnew murein, became evident when transpeptidation was studied in the presence of (-lactam antibiotics and in mutants defective in penicillin-binding proteins.
Addition of antibiotics known to interfere with the insertion of new murein into the sacculus, such as ampicillin and cephaloridine (17) , blocked the insertion of new murein at the concentrations used. Upon addition of the antibiotics, the in- However, an immediate increase in the crosslinkage in the murein synthesized before addition of the drug (after 3 min of incubation, before any autolysis is detectable) was observed, whereas the crosslinkage of total murein remained constant ( Fig. 3 ; Table 1 ). This shows the relative insensitivity ofthe second transpeptidation system to these antibiotics. Cephalexin and piperacillin, however, while allowing the insertion of new (Fig. la) .
t Values are given as molar fraction of crosslinked dimers (see legend to Fig. la) .
* Percentage of total radioactivity in murein (Fig. 4) (20) . The time courses of attachment of lipoprotein to newly synthesized murein and of crosslink formation (Fig. 4) showed a remarkable similarity: newly synthesized, pulse-labeled murein carries about 70% of the amount of lipoprotein found in uniformly labeled murein. This observation has been published previously (21) ; interestingly, in this report a reduced crosslinkage ofnewly synthesized murein was also concealed in the data.
A correlation between processing of murein and the attachment of lipoprotein was also found in mutants in which either lipoprotein biosynthesis (22) (1981) tants this speculation could be tested by high-resolution autoradiography as used for the study of the growth pattern of murein (3, 4) . Why has such a complicated sequence ofevents been maintained during evolution if cells in which processing of murein does not occur survive-at least under laboratory conditions? This latter may be the important limitation; in free nature the same defect may mean cell death.
